Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: WATCHMAN FLX Pro European Registry [NA]

View source ↗

Summary

The WATCHMAN FLX Pro European Registry is currently recruiting to study left atrial appendage closure in patients with non-valvular atrial fibrillation. The reg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Non-valvular Atrial Fibrillation (AF), Left Atrial Appendage Closure | NA | Status: RECRUITING